Zależności pomiędzy tkanką kostną a tkanką tłuszczową

• Autorzy: Bienko M. , Lis A. , Wolski D. , Radzki R.P.

Warianty tytułu

EN

Relationships between bone tissue and fat tissue

• Języki publikacji: PL

Abstrakty

EN

Despite its apparent stability, bone tissue is an extremely dynamic structure, responding to diverse and multidirectional interactions by changes in its metabolism. Adipose tissue is no longer seen as a mere store of energy reserves for the organism, but is also recognized as an important endocrine organ. There are several relationships between the two types of tissue, which result from the influence of fat tissue on bone tissue. This influence is expressed through a direct influence of adipokines on bone metabolism and through indirect effects and regulatory impact of adipose tissue on other hormones associated with the metabolism of bone tissue. Osteotropic effects of adipose tissue also result from mechanical load on the skeleton. The aim of this paper was to present the mechanisms of mutual interactions between adipose tissue and bone tissue. The authors also tried to answer the question of whether obesity promotes the development of osteoporosis or whether it is a protective factor for the skeletal system.

Słowa kluczowe

PL

fizjologia zwierzat; tkanka tluszczowa; adipocyty; funkcje wydzielnicze; adiponektyna; leptyna; interleukina 6; estrogeny; androgeny; oddzialywanie na tkanke kostna; tkanka kostna; metabolizm; otylosc; osteoporoza

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2016
• Tom: 72
• Numer: 04
• Opis fizyczny: s.217-221,bibliogr.

Twórcy

autor

Bienko M.

• Katedra Fizjologii Zwierząt, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul. Akademicka 12, 20-033 Lublin

autor

Lis A.

• Katedra Fizjologii Zwierząt, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul. Akademicka 12, 20-033 Lublin

autor

Wolski D.

• Katedra Fizjologii Zwierząt, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul. Akademicka 12, 20-033 Lublin

autor

Radzki R.P.

• Katedra Fizjologii Zwierząt, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul. Akademicka 12, 20-033 Lublin

Bibliografia

• Ahmed L. A., Schirmer H., Berntsen G. K., Fonnebo V., Joakimsen R. M.: Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromso study. Osteoporos. Int. 2006, 17, 426-432.
• Aitken S. J., Landao-Bassonga E., Ralston S. H., Idris A. I.: Beta2-adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms. Arch. Biochem. Biophys. 2009, 482, 96-103.
• Albuquerque Maia L. D., Lisboa P. C., De Oliveira E., Silva Da Lima N., Lima I. C., Lopes R. T., Ruffoni L. D., Nonaka K. O., Moura De E. G.: Bone metabolism in obese rats programmed by early weaning. Metabolism 2014, 63, 352-364.
• Bado A., Levasseur S., Attoub S., Kermorgant S., Laigneau J. P., Bortoluzzi M. N., Moizo L., Lehy T., Guerre-Millo M., Le Marchand-Brustel Y., Lewin M. J.: The stomach is a source of leptin. Nature 1998, 394, 790-793.
• Bellido T., O’brien C. A., Roberson P. K., Manolagas S. C.: Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J. Biol. Chem. 1998, 273, 21137-21144.
• Benedetti F. D., Rucci N., Del Fattore A., Peruzzi B., Paro R., Longo M., Vivarelli M., Muratori F., Berni S., Ballanti P., Ferrari S., Teti A.: Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis. Rheum. 2006, 54, 3551-3563.
• Blum M., Dolnikowski G., Seyoum E., Harris S. S., Booth S. L., Peterson J., Saltzman E., Dawson-Hughes B.: Vitamin D(3) in fat tissue. Endocrine 2008, 33, 90-94.
• Borst S. E.: Interventions for sarcopenia and muscle weakness in older people. Age Ageing 2004, 33, 548-555.
• Boyce B. F., Xing L.: The RANKL/RANK/OPG pathway. Curr. Osteoporos. Rep. 2007, 5, 98-104.
• Burguera B., Hofbauer L. C., Thomas T., Gori F., Evans G. L., Khosla S., Riggs B. L., Turner R. T.: Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 2001, 142, 3546-3553.
• Christakos S., Dhawan P., Porta A., Mady L. J., Seth T.: Vitamin D and intestinal calcium absorption. Mol. Cell Endocrinol. 2011, 347, 25-29.
• Cornish J., Callon K. E., Bava U., Lin C., Naot D., Hill B. L., Grey A. B., Broom N., Myers D. E., Nicholson G. C., Reid I. R.: Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 2002, 175, 405-415.
• Ding C., Gao D., Wilding J., Trayhurn P., Bing C.: Vitamin D signalling in adipose tissue. Br. J. Nutr. 2012, 108, 1915-1923.
• Ducy P., Amling M., Takeda S., Priemel M., Schilling A. F., Beil F. T., Shen J., Vinson C., Rueger J. M., Karsenty G.: Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 100, 197-207.
• Edney A. T., Smith P. M.: Study of obesity in dogs visiting veterinary practices in the United Kingdom. Vet. Rec. 1986, 118, 391-396.
• Fernandez J. R., Garcia-Aznar J. M., Martinez R.: Piezoelectricity could predict sites of formation/resorption in bone remodelling and modelling. J. Theor. Biol. 2012, 292, 86-92.
• Fontana L., Eagon J. C., Trujillo M. E., Scherer P. E., Klein S.: Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007, 56, 1010-1013.
• Frank N.: Equine metabolic syndrome. Vet. Clin. North. Am. Equine Pract. 2011, 27, 73-92.
• Fukada E., Yasuda I.: On the Piezoelectric Effect of Bone. J. Phys. Soc. Jpn. 1957, 12, 1158-1162.
• Gerbaix M., Metz L., Mac-Way F., Lavet C., Guillet C., Walrand S., Masgrau A., Vico L., Courteix D.: A well-balanced diet combined or not with exercise induces fat mass loss without any decrease of bone mass despite bone micro-architecture alterations in obese rat. Bone 2013, 53, 382-390.
• Gimble J. M., Nuttall M. E.: The relationship between adipose tissue and bone metabolism. Clin. Biochem. 2012, 45, 874-879.
• Giustina A., Mazziotti G., Canalis E.: Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 2008, 29, 535-559.
• Gower B. A., Casazza K.: Divergent effects of obesity on bone health. J. Clin. Densitom. 2013, 16, 450-454.
• Hamrick M. W., Ferrari S. L.: Leptin and the sympathetic connection of fat to bone. Osteoporos. Int. 2008, 19, 905-912.
• Hofbauer L. C., Heufelder A. E.: Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J. Mol. Med. (Berl) 2001, 79, 243-253.
• Hofbauer L. C., Khosla S., Dunstan C. R., Lacey D. L., Spelsberg T. C., Riggs B. L.: Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 1999, 140, 4367-4370.
• Holloway W. R., Collier F. M., Aitken C. J., Myers D. E., Hodge J. M., Malakellis M., Gough T. J., Collier G. R., Nicholson G. C.: Leptin inhibits osteoclast generation. J. Bone Miner. Res. 2002, 17, 200-209.
• Hwang D. K., Choi H. J.: The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos. Int. 2010, 21, 425-431.
• Iwaniec U. T., Shearon C. C., P. H. R., Cullen D. M.: Leptin increases number of mineralized Bone nodules in vitro. Int. Bone Min. Soc. 1998, 23, T036.
• Kalra S. P., Kalra P. S.: Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 2003, 22, 49-56.
• Kershaw E. E., Flier J. S.: Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004, 89, 2548-2556.
• Kong J., Li Y. C.: Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am. J. Physiol. Endocrinol. Metab. 2006, 290, E916-924.
• Kuhn M. C., Willenberg H. S., Schott M., Papewalis C., Stumpf U., Flohe S., Scherbaum W. A., Schinner S.: Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. Mol. Cell Endocrinol. 2012, 349, 180-188.
• Lee H. W., Kim S. Y., Kim A. Y., Lee E. J., Choi J. Y., Kim J. B.: Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells 2009, 27, 2254-2262.
• Lenchik L., Register T. C., Hsu F. C., Lohman K., Nicklas B. J., Freedman B. I., Langefeld C. D., Carr J. J., Bowden D. W.: Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003, 33, 646-651.
• Li Y., Backesjo C. M., Haldosen L. A., Lindgren U.: IL-6 receptor expression and IL-6 effects change during osteoblast differentiation. Cytokine 2008, 43, 165-173.
• Lin H., Li Z.: Adiponectin self-regulates its expression and multimerization in adipose tissue: an autocrine/paracrine mechanism? Med. Hypotheses 2012, 78, 75-78.
• Luo X. H., Guo L. J., Xie H., Yuan L. Q., Wu X. P., Zhou H. D., Liao E. Y.: Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J. Bone Miner. Res. 2006, 21, 1648-1656.
• Margetic S., Gazzola C., Pegg G. G., Hill R. A.: Leptin: a review of its peripheral actions and interactions. Int. J. Obes. Relat. Metab. Disord. 2002, 26, 1407-1433.
• Masuzaki H., Ogawa Y., Sagawa N., Hosoda K., Matsumoto T., Mise H., Nishimura H., Yoshimasa Y., Tanaka I., Mori T., Nakao K.: Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat. Med. 1997, 3, 1029-1033.
• Meseguer A., Puche C., Cabero A.: Sex steroid biosynthesis in white adipose tissue. Horm. Metab. Res. 2002, 34, 731-736.
• Mrak E., Villa I., Lanzi R., Losa M., Guidobono F., Rubinacci A.: Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells. J. Endocrinol. 2007, 192, 639-645.
• Okopien B., Krysiak R., Labuzek K., Herman Z. S.: Anabolic therapy in osteoporosis – part 1. Pol. Merkur. Lek. 2005, 18, 712-714.
• Oshima K., Nampei A., Matsuda M., Iwaki M., Fukuhara A., Hashimoto J., Yoshikawa H., Shimomura I.: Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun. 2005, 331, 520-526.
• Pacheco-Pantoja E. L., Waring V. J., Wilson P. J., Fraser W. D., Gallagher J. A.: Adiponectin receptors are present in RANK-L-induced multinucleated osteoclast-like cells. J. Recept. Signal. Transduct. Res. 2013, 33, 291-297.
• Pasco J. A., Henry M. J., Kotowicz M. A., Collier G. R., Ball M. J., Ugoni A. M., Nicholson G. C.: Serum leptin levels are associated with bone mass in nonobese women. J. Clin. Endocrinol. Metab. 2001, 86, 1884-1887.
• Reseland J. E., Syversen U., Bakke I., Qvigstad G., Eide L. G., Hjertner O., Gordeladze J. O., Drevon C. A.: Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J. Bone Miner. Res. 2001, 16, 1426-1433.
• Riggs B. L.: The mechanisms of estrogen regulation of bone resorption. J. Clin. Invest. 2000, 106, 1203-1204.
• Rosen C. J., Bouxsein M. L.: Mechanisms of disease: is osteoporosis the obesity of bone? Nat. Clin. Pract. Rheumatol. 2006, 2, 35-43.
• Saad M. F., Riad-Gabriel M. G., Khan A., Sharma A., Michael R., Jinagouda S. D., Boyadjian R., Steil G. M.: Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity. J. Clin. Endocrinol. Metab. 1998, 83, 453-459.
• Scherer P. E., Williams S., Fogliano M., Baldini G., Lodish H. F.: A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 1995, 270, 26746-26749.
• Snijder M. B., Van Dam R. M., Visser M., Deeg D. J., Dekker J. M., Bouter L. M., Seidell J. C., Lips P.: Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J. Clin. Endocrinol. Metab. 2005, 90, 4119-4123.
• Sowers M. F., Kshirsagar A., Crutchfield M. M., Updike S.: Joint influence of fat and lean body composition compartments on femoral bone mineral density in premenopausal women. Am. J. Epidemiol. 1992, 136, 257-265.
• Streeter A. J., Hosking J., Metcalf B. S., Jeffery A. N., Voss L. D., Wilkin T. J.: Body fat in children does not adversely influence bone development: a 7-year longitudinal study (EarlyBird 18). Pediatr. Obes. 2013, 8, 418-427.
• Thomas T., Burguera B., Melton L. J., 3rd, Atkinson E. J., O’fallon W. M., Riggs B. L., Khosla S.: Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 2001, 29, 114-120.
• Trayhurn P., Wood I. S.: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 2004, 92, 347-355.
• Turner R. T., Iwaniec U. T.: Moderate weight gain does not influence bone metabolism in skeletally mature female rats. Bone 2010, 47, 631-635.
• Tvarijonaviciute A., Ceron J. J., Holden S. L., Cuthbertson D. J., Biourge V., Morris P. J., German A. J.: Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome. BMC Vet. Res. 2012, 8, 147.
• Wagner D., Fahrleitner-Pammer A.: Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help? Wien. Med. Wochenschr. 2010, 160, 452-457.
• Wang M. C., Bachrach L. K., Van Loan M., Hudes M., Flegal K. M., Crawford P. B.: The relative contributions of lean tissue mass and fat mass to bone density in young women. Bone 2005, 37, 474-481.
• Wang Y., Wang J. Q.: Standard definition of child overweight and obesity worldwide. Authors’ standard compares well wil WHO standard. BMJ 2000, 321, 1158.
• Wiesner G., Vaz M., Collier G., Seals D., Kaye D., Jennings G., Lambert G., Wilkinson D., Esler M.: Leptin is released from the human brain: influence of adiposity and gender. J. Clin. Endocrinol. Metab. 1999, 84, 2270-2274.
• Zhou J., Zhang Q., Yuan X., Wang J., Li C., Sheng H., Qu S., Li H.: Association between metabolic syndrome and osteoporosis: a meta-analysis. Bone 2013, 57, 30-35.
• Zoran D. L.: Obesity in dogs and cats: a metabolic and endocrine disorder. Vet. Clin. North. Am. Small Anim. Pract. 2010, 40, 221-239.